The burden associated with, and management of, difficult-to-treat depression in patients under specialist psychiatric care in the United Kingdom

J Psychopharmacol. 2022 May;36(5):545-556. doi: 10.1177/02698811221090628. Epub 2022 May 4.

Abstract

Background: Major depressive disorder (MDD) is common and often has sub-optimal response to treatment. Difficult-to-treat depression (DTD) is a new concept that describes 'depression that continues to cause significant burden despite usual treatment efforts'.

Aims: To identify patients with likely DTD in UK secondary care and examine demographic, disease and treatment data as compared with 'non-DTD' MDD patients.

Methods: Anonymised electronic health records (EHRs) of five specialist mental health National Health Service (NHS) Trusts in the United Kingdom were analysed using a natural language processing model. Data on disease characteristics, comorbidities and treatment histories were extracted from structured fields and using natural language algorithms from unstructured fields. Patients with MDD aged ⩾18 years were included in the analysis; those with presumed DTD were identified on the basis of MDD history (duration and recurrence) and number of treatments prescribed.

Results: In a sample of 28,184 patients with MDD, 19% met criteria for DTD. Compared to the non-DTD group, patients with DTD were more likely to have severe depression, suicidal ideation, and comorbid psychiatric and/or physical illness, as well as higher rates of hospitalisation. They were also more likely to be in receipt of unemployment and sickness/disability benefits. More intensive treatment strategies were used in the DTD group, including higher rates of combination therapy, augmentation, psychotherapy and electroconvulsive therapy.

Conclusion: This study demonstrates the feasibility of identifying patients with probable DTD from EHRs and highlights the increased burden associated with MDD in these patients.

Keywords: Difficult-to-treat depression; antidepressants; burden of disease; burden of illness; clinical management; drugs for depression; drugs for psychosis; drugs for relapse prevention; hospital admission; treatment-resistant depression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Depression / therapy
  • Depressive Disorder, Major* / epidemiology
  • Depressive Disorder, Major* / psychology
  • Depressive Disorder, Major* / therapy
  • Humans
  • Psychotherapy
  • State Medicine
  • Suicidal Ideation